Xigduo XR Side Effects Listed In FDA Safety Communication

In a December 2015 safety communication, the U.S. Food and Drug Administration (FDA) added Xigduo XR side effects warnings to the labels of the diabetes drug, along with the labels of other SGLT2 inhibitors. Xigduo XR combines the two active ingredients dapagliflozin and metformin extended-release. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes, bad drug attorneys note.

If you or a loved one suffered complications after taking Xigduo XR, contact Attorney Group today to discuss your options in a free, confidential, no-obligation consultation. We can answer your questions, and if you decide to pursue a claim for compensation, we can connect you with an affiliated Xigduo XR lawsuit attorney who can assist you throughout the legal process.

Important: The time you have to pursue a claim is limited. Contact us for more information.

High Blood Acid Risk Among Potential Xigduo XR Side Effects

Xigduo XR is manufactured by AstraZeneca and was approved by the FDA in 2014 to treat type 2 diabetes. According to the safety communication released by the FDA, the diabetes drug and others in its class of SGLT2 inhibitors may lead to an increased risk of ketoacidosis, a serious condition where the body produces high levels of blood acids call ketones, a condition that may require hospitalization.

In addition to Xigduo XR, other SGLT2 inhibitors included in the FDA warning are marketed under the following names:

  • Jardiance (empagliflozin)
  • Farxiga (dapagliflozin)
  • Invokana (canagliflozin)
  • Glyxambi (empagliflozin and linagliptin)
  • Invokamet (canagliflozin and metformin)

The FDA indicated that some users of SGLT2 inhibitor diabetes drugs, like Xigduo XR, may require hospitalization or emergency room treatment after suffering symptoms of ketoacidosis. These symptoms may include:

  • Abdominal pain
  • Nausea or vomiting
  • Confusion, Sleepiness or fatigue
  • Difficulty breathing

The FDA also cautions patients using Xigduo XR to be alert for signs and symptoms of a urinary tract infection, such as a feeling of burning when urinating or the need to urinate often or right away; pain in the lower part of the stomach area or pelvis; fever; or blood in the urine.

Injured Patients May Be Entitled to Compensation

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

Patients who have been injured by Xigduo XR may be entitled to compensation for damages, including:

  • Medical expenses
  • Pain, suffering, and mental anguish
  • Loss of income or ability to work

If a patient dies from complications after taking Xigduo XR, his or her family members may be able to pursue claims for their loved one’s wrongful death. Compensation may include:

  • Pain, suffering, and mental anguish from the loss of a loved one
  • Loss of financial support of a loved one
  • Funeral expenses

Affected patients are encouraged to speak with a Xigduo XR lawsuit attorney to learn more about their rights and remedies.

Contact Us For More Information

If you or a loved one took Xigduo XR and suffered complications, contact Attorney Group for more information. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at info@attorneygroup.com.

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group today.

Comments